COMMUNIQUÉS West-GlobeNewswire

Evolus Accelerates Next Phase of U.S. Launch of Jeuveau™ with ‘#NEWTOX NOW’ Consumer Conversion Program
05/06/2019
NEWPORT BEACH, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today announced the launch of the ‘#NEWTOX NOW’ consumer conversion program following the rapid adoption of the company’s Jeuveau™ [...]
Centrexion Therapeutics Announces Completion of Patient Enrollment in Pivotal Clinical Trial of Repeat Doses of CNTX-4975 in Patients with Moderate to Severe Osteoarthritis Knee Pain
05/06/2019
BOSTON, June 05, 2019 (GLOBE NEWSWIRE) -- Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain, today announced completion of [...]
OrthoPediatrics Announces Acquisition of Vilex and Novel External Fixation Technology
05/06/2019
The Company to host conference call today at 8:30am ET WARSAW, Ind., June 05, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing the field of [...]
Neuronetics to Present at the JMP Life Sciences Conference
05/06/2019
MALVERN, Pa., June 05, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for [...]
ProMIS Neurosciences Presents Lead Program for Alzheimer’s Disease at Prestigious Keystone Symposia Scientific Conference
05/06/2019
Neurodegenerative Diseases: New Insights and Therapeutic Opportunities to advance discussion about therapies for Alzheimer’s disease among world’s leading researchers TORONTO and CAMBRIDGE, Mass., June 05, 2019 (GLOBE [...]
Blueberries Announces Cannabis Sales and Distribution Agreement for German Market
05/06/2019
TORONTO, June 05, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a leading Latin American licensed producer of medicinal cannabis and [...]
Media Advisory/TODAY: Montreal’s Four Leading Pediatric Institutions to Announce Largest Collaboration in Canadian History to Help Children with Musculoskeletal Disorders
05/06/2019
MONTREAL, June 05, 2019 (GLOBE NEWSWIRE) -- The largest collaboration of its kind in Canadian history will be announced today, June 5, 2019, by the foundations of the CHU Sainte-Justine and its Marie Enfant [...]
Avis aux médias : Les quatre principaux établissements pédiatriques montréalais annonceront AUJOURD’HUI la plus importante collaboration de l’histoire du Canada pour aider les enfants atteints de troubles musculosquelettiques
05/06/2019
MONTRÉAL, 05 juin 2019 (GLOBE NEWSWIRE) -- La plus importante collaboration du genre dans l’histoire du Canada sera annoncée aujourd’hui, le 5 juin 2019, par les fondations du CHU Sainte-Justine et de son Centre de [...]
Helius Medical Technologies, Inc. Announces Addition of Three New PoNS™ Authorized Clinics in Canada
05/06/2019
NEWTOWN, Pa., June 05, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported that three new [...]
Myriad Genetics to Present at the 2019 Goldman Sachs Global Healthcare Conference
05/06/2019
SALT LAKE CITY, June 05, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled [...]
NGM Bio to Present New Data from Phase 1b Study of NGM313 at 79th Scientific Sessions of the American Diabetes Association
05/06/2019
SOUTH SAN FRANCISCO, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a clinical stage biotechnology company focused on developing transformative therapeutics for patients, today [...]
Scilex Holding Announces Strong ZTlido Sales Growth After Successful Post-Merger Integration
05/06/2019
ZTlido ® gross sales grew from approximately $1 million in March to $2.4 million in April and $3.3 million in May SP-102 pivotal phase 3 trial remains on track for completion in H1 2020 ZTlido ® 5.4% (3 X strength) [...]
AnaptysBio Presents Updated Data from Etokimab Phase 2a Proof-of-Concept Clinical Trial in Severe Eosinophilic Asthma
05/06/2019
Single dose of etokimab resulted in rapid and sustained lung function improvement and ACQ-5 score reduction through at least Day 64 Etokimab was well tolerated and no serious adverse events were reported Data supports [...]
BeiGene to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
05/06/2019
CAMBRIDGE, Mass. and BEIJING, China, June 05, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Teleflex to Present at the Raymond James Life Sciences and MedTech Conference
05/06/2019
WAYNE, Pa., June 05, 2019 (GLOBE NEWSWIRE) -- Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James Life Sciences and MedTech [...]
TRU NIAGEN® Awarded ‘Ingredient of the Year: Healthy Aging’ by NutraIngredients-USA
05/06/2019
ChromaDex receives industry award for its safety record and the robust research behind its NAD-boosting ingredient, Tru Niagen (nicotinamide riboside) LOS ANGELES, June 05, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. ( [...]
The Ensign Group Acquires Texas Post-Acute Care Campus
05/06/2019
MISSION VIEJO, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]
Neovacs to present the pre-clinical results of its IFNalpha Kinoid to treat type 1 diabetes - American Diabetes Association's 79th scientific sessions
05/06/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS TO PRESENT THE PRE-CLINICAL RESULTS OF ITS IFNα KINOID TO TREAT TYPE 1 DIABETES AT T HE AMERICAN DIABETES ASSOCIATION'S 79TH SCIENTIFIC SESSIONS (ADA) “IFNα Kinoid: [...]
Néovacs présente les résultats précliniques de l'IFNalpha Kinoïde pour le traitement du diabète de type 1 - 79ème conférence scientifique de l'American Diabetes Association
05/06/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS PRÉSENTE LES R É SULTATS PR É CLINIQUES DE L’IFN α KINO Ϊ DE POUR LE TRAITEMENT DU DIAB È TE DE TYPE 1 LORS DE LA 79 EME CONF É RENCE [...]

Pages